Plano Orthopedic Sports Medicine and Spine Center, Plano, Texas, USA.
Arthroscopy. 2011 Aug;27(8):1029-35. doi: 10.1016/j.arthro.2011.06.010.
To assess the effect of platelet-rich plasma fibrin matrix (PRPFM) construct augmentation on postoperative tendon healing as determined by magnetic resonance imaging (MRI) and clinical outcome of arthroscopic rotator cuff repair.
A comparative series of patients undergoing arthroscopic rotator cuff repair was studied. Two matched groups of patients (20 each) were included: rotator cuff repairs without PRPFM augmentation (group 1) and rotator cuff repairs augmented with 2 sutured platelet-rich plasma (PRP) constructs (group 2). A single-row cuff repair to the normal footprint without tension or marrow vents was performed by a single surgeon. Postoperative rehabilitation was held constant. Postoperative MRI scans were used to evaluate rotator cuff healing. Outcome measures included American Shoulder and Elbow Surgeons, Rowe, Single Assessment Numeric Evaluation, Simple Shoulder Test, and Constant scores.
We followed up 40 patients (2 matched groups with 20 patients each) with a mean age of 57 years (range, 44 to 69 years) for a mean of 31 months (range, 24 to 44 months). Postoperative MRI studies showed persistent full-thickness tendon defects in 60% of controls (12 of 20) and 30% of PRPFM-augmented repairs (6 of 20) (P = .03). Of the control group tears measuring less than 3 cm in anteroposterior length, 50% (7 of 14) healed fully, whereas 86% of the PRPFM group tears measuring less than 3 cm in anteroposterior length (12 of 14) healed fully (P < .05). There was no significant difference between groups 1 and 2 in terms of American Shoulder and Elbow Surgeons (94.7 and 95.7, respectively; P = .35), Single Assessment Numeric Evaluation (93.7 and 94.5, respectively; P = .37), Simple Shoulder Test (11.4 and 11.3, respectively; P = .41), and Constant (84.7 and 88.1, respectively; P = .19) scores. The Rowe scores (84.8 and 94.9, respectively; P = .03) were statistically different.
The addition of 2 PRPFM constructs sutured into a primary rotator cuff tendon repair resulted in lower retear rates identified on MRI than repairs without the constructs. Other than the Rowe scores, there was no postoperative clinical difference by use of standard outcome measures.
Level III, case-control study.
通过磁共振成像(MRI)和关节镜肩袖修复的临床结果评估富血小板纤维蛋白基质(PRPFM)构建物增强对术后腱愈合的影响。
研究了接受关节镜肩袖修复的一系列比较患者。纳入了两组匹配的患者(每组 20 例):未增强 PRPFM 的肩袖修复组(1 组)和用 2 个缝合的富血小板血浆(PRP)构建物增强的肩袖修复组(2 组)。由同一位外科医生进行常规足印区的单排肩袖修复,不进行张力或骨髓通风。术后康复保持不变。术后 MRI 扫描用于评估肩袖愈合。结果测量包括美国肩肘外科医师、Rowe、单项评估数值评估、简单肩部测试和常数评分。
我们随访了 40 名患者(每组 20 名,每组 2 名),平均年龄 57 岁(范围,44 至 69 岁),平均随访 31 个月(范围,24 至 44 个月)。术后 MRI 研究显示,对照组中有 60%(20 例中有 12 例)和 PRPFM 增强修复组中有 30%(20 例中有 6 例)存在持续的全层腱缺损(P =.03)。在前后长度小于 3 厘米的对照组撕裂中,50%(14 例中有 7 例)完全愈合,而 PRPFM 组中在前后长度小于 3 厘米的撕裂中,86%(14 例中有 12 例)完全愈合(P <.05)。组 1 和组 2 之间在以下方面没有显著差异:美国肩肘外科医师(分别为 94.7 和 95.7;P =.35)、单项评估数值评估(分别为 93.7 和 94.5;P =.37)、简单肩部测试(分别为 11.4 和 11.3;P =.41)和常数(分别为 84.7 和 88.1;P =.19)评分。Rowe 评分(分别为 84.8 和 94.9;P =.03)存在统计学差异。
与未使用构建物的修复相比,将 2 个缝合的 PRPFM 构建物缝合到原发性肩袖肌腱修复中可降低 MRI 上的再撕裂率。除了 Rowe 评分外,使用标准结果测量方法没有术后临床差异。
III 级,病例对照研究。